Skip to main content

Clinical trial IJB_2724

A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 in Combination With Immune Therapies in Subjects With Advanced or Metastatic Malignancies

Organ solid tumors
Trial status Trial open for recruitment
Trial type
Prospective interventional
Phase Trial phase 1/2
Academic trial Non
Sponsor Incyte Corporate
EudraCT Identifier 2016-004989-25
Inclusion criteria second line RECIST 1.1 Biopsy
Last update

Follow us!

Support research

Support research

Research at the Institut Jules Bordet depends on your generosity. Make a donation today and join us in the fight against cancer.

Learn more